Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
658 studies found for:    Vaginal Diseases: Clinical Trials
Show Display Options
Rank Status Study
1 Completed Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
Condition: Vaginosis, Bacterial
Intervention: Device: Vaginal ring releasing lactic acid (racemic mixture)
2 Completed Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
Condition: Bacterial Vaginosis
Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel;   Other: hygienic information
3 Completed
Has Results
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal acidifying gel (RepHresh);   Drug: Metronidazole control
4 Recruiting Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Drug: 5% Monolaurin Vaginal Gel;   Other: Placebo
5 Recruiting Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Condition: Recurrent Bacterial Vaginosis
Interventions: Drug: Metronidazole (male partner);   Other: Placeob (male partner)
6 Completed Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis
Condition: Bacterial Vaginosis
Intervention: Drug: Trimo-San gel
7 Completed Lcr35® for Bacterial Vaginosis Prevention
Condition: Bacterial Vaginosis
Interventions: Drug: placebo;   Drug: Lcr35®
8 Completed Rwanda VMB Restoration Study
Condition: Bacterial Vaginosis
Interventions: Biological: Vaginal probiotics for prevention of BV recurrence (Ecologic Femi vaginal capsule);   Drug: Prophylactic use of metronidazole pills (500 mg);   Biological: Vaginal probiotics for prevention of BV recurrence (Gynophilus vaginal tablet)
9 Recruiting LACTIN-V Study for Recurrent Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Biological: Lactobacillus crispatus CTV-05;   Drug: Metronidazole;   Other: Placebo
10 Completed Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
Condition: Pregnancy
Interventions: Drug: Clindamycin;   Drug: Placebo
11 Terminated Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
Conditions: Vaginosis, Bacterial;   Infertility;   Miscarriage
Interventions: Drug: Metronidazole;   Drug: Placebo
12 Completed
Has Results
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 30 mg;   Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Nonhormonal vaginal lubricant
13 Completed
Has Results
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Placebo;   Drug: Ospemifene 5 mg;   Drug: Ospemifene 15 mg;   Drug: Ospemifene 30 mg
14 Completed
Has Results
A Clinical Study to Evaluate the Safety of Ospemifene
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo
15 Completed
Has Results
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Non-hormonal vaginal lubricant
16 Completed
Has Results
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Conditions: Atrophy;   Vaginal Diseases
Intervention: Drug: Ospemifene
17 Completed
Has Results
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene (Dose 1);   Drug: Ospemifene (Dose 2);   Drug: Placebo
18 Unknown  Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy
Condition: Bacterial Vaginosis
Interventions: Drug: Lactobacillus acidophilus;   Drug: Placebo
19 Terminated Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
Conditions: Bacterial Vaginosis;   Premature Birth;   Sepsis;   Periventricular Leukomalacia;   Bronchopulmonary Dysplasia
Intervention: Drug: Lactobacillus rhamnosus GR1 and Lactobacillus reuteri RC-14
20 Completed Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Other: probiotic yoghurt;   Other: chemically acidified milk;   Drug: Arilin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.